ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
29.01
+0.77 (2.73%)
At close: Aug 17, 2026, 4:00 PM EDT
29.42
+0.41 (1.43%)
Pre-market: Aug 18, 2026, 7:02 AM EDT

ACADIA Pharmaceuticals Revenue

ACADIA Pharmaceuticals had revenue of $307.96M in the quarter ending June 30, 2026, with 16.40% growth. This brings the company's revenue in the last twelve months to $1.14B, up 11.75% year-over-year. In the year 2025, ACADIA Pharmaceuticals had annual revenue of $1.07B with 11.87% growth.

Revenue (ttm)
$1.14B
Revenue Growth
+11.75%
P/S Ratio
4.39
Revenue / Employee
$1,426,872
Employees
798
Market Cap
5.00B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.07B113.71M11.87%
Dec 31, 2024957.80M231.36M31.85%
Dec 31, 2023726.44M209.20M40.45%
Dec 31, 2022517.24M33.09M6.83%
Dec 31, 2021484.15M42.39M9.60%
Dec 31, 2020441.76M102.68M30.28%
Dec 31, 2019339.08M115.27M51.50%
Dec 31, 2018223.81M98.91M79.19%
Dec 31, 2017124.90M107.57M620.68%
Dec 31, 201617.33M17.27M28,311.48%
Dec 31, 201561.00K-59.00K-49.17%
Dec 31, 2014120.00K-1.03M-89.52%
Dec 31, 20131.15M-3.76M-76.67%
Dec 31, 20124.91M2.84M137.40%
Dec 31, 20112.07M-40.07M-95.09%
Dec 31, 201042.14M35.74M558.46%
Dec 31, 20096.40M4.81M302.45%
Dec 31, 20081.59M-5.97M-78.95%
Dec 31, 20077.56M-578.00K-7.11%
Dec 31, 20068.13M-2.82M-25.77%
Dec 31, 200510.96M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.